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IN earlier work on the mammotrophic activity present in women's urine,
intact weanling male mice of a Swiss Schneider strain (SAS3) were used as test
objects (Hadfield and Young, 1956a, b). The injection of urine or urine extracts
into such mice stimulated development of the mammary glands as shown b.N,
extension of the duct system and an increase in the number of end buds or clubs.
Similaractivity was possessedby oestrone andbyprolactin.
Gradually the commercially-bred SAS3 mice lost sensitivity under test and
they were replaced by mice of the inbred A2G strain. This was the only other
strain out of 37 examined in which the mammary glands ofweanling males were
responsive to both prolactin and urine (Young, 1957).
The mammotrophic activity in urine was believed to be due to protein
hormone(s) from the hypophysis and it was therefore considered advisable to
continue the workusinghypophysectomized micegivenpartial steroidreplacement
JA7,ith oestrone and progesterone (Hadfield, 1957).
The mammary glands of the hypophysectomized immature males of the A2('A-
strain failed torespond to oestrone plus progesterone or to prolactin or urine alone
but responded to combined treatment with all three hormones or to urine given
with oestrone and progesterone. Serum from normal women was also effective in
combination with the two steroid hormones (Hadfield and Young, 1958).
Thepresent paperreports asomewhat unsuccessfulattempt to extend this work.
We had hoped to be able to measure the mammotrophic activity in human urine
and blood, in order to establish normal values and study variations. This has,
however, proved virtually impossible with the test system used, because the
responsiveness of the mice to prolactin has diminished. Neat urine is now seldom
effective in the test and though mammotrophic activity has again been demon-
strated unequivocallv in women's serum, the amount can be estimated onl very
roughly.
MATERIALS AND METHODS
Animals
Mice of the A2G strain were bred in our laboratories from random matings of
trios replenished every 3-4 generations with fresh stock from the Laboratorv
Animals Centre.
Males were hypophysectomized when 22-26 days old and 10-15 g. in weight.
These were fed on diet 41B supplemented with rolled oats and had access to water
throughout. After operation they were kept at a temperature of 78' C. The mice244 FRASER, SPICER, WILLIAMS AND STRETTON YOUNG
were weighed at operation and when due for their first injection; any that had
gained more than 10 per cent inweight at this time were discarded (cf Young and
Fraser, 1960).
Hormone8
Oestrone wasdissolvedinarachis oil orbought as anaqueoussolution(Organon).
Progesterone was dissolved in arachis oil or bought as a suspension in an aqueous medium (Laboratories for Applied Biology, Ltd.). Ovine prolactin (Batch No.
U10405) and bovinegrowth hormone (BatchNo. R50109), both from the National
Institutes ofHealth, U.S.A., were dissolved in isotonic sahne.
Each of the two latter preparations was known to be contaminated by small
amounts of other pituitary hormones.
Urine and blood
Samples of urine (Table I) were coRected early on the morning when the mice
were due for their first injection and were stored at 4' C. during the injection period.
Blood samples(Table II) were left to clot at 37' C. and cooled at 4' C. before
the serum was removed. The serum was then stored at 4' C. until needed for test.
Injection8
Injections were started 4-7days afterhypophysectomy. Theoriginalprocedure
was for two injections to be given daily for 5 days. Oestrone and progesterone dissolved in arachis oil were injected subcutaneously into one flank each morning and the material to be tested was injected into the other flank. The respective injection sites were reversed for theeveninginjections. The total doses ofhormone
were originaHy : oestrone, 1 ug.; progesterone, 5 mg.; prolactin, 5 i.u. This
injection schedule was later simpfified and dosages were reduced as explained in
the text. The total dose of urine per mouse was 4 ml. and of serum I ml. in all
tests.
A88m8mentofmammotrophic activity
The mice were killed and skinned on the morning of the 6th day and the
mammaryglands fixed and stained in8itu beforebeing dissected from thepelt and
mounted whole. The mammotrophic activity was then measured by counting the number of clubs (sweflings of the duct endings more than twice the diameter
of the duct itself) and expressing this for each group of animals as the average number of clubs per mouse (Hadfield and Young, 1956a).
RESULTS
Te8t8 ofnormal urine
Samples of urine from 2 normal young women kiRed all the mice into which
they were injected. Three of the rem
i i 11 samples from 9 young women
stimulated significant, though small, increases in club count (Table I). These
active samples were not confined to any phase of the menstrual cycle and second
samples (MW/2 and JF/2) from 2 of the women producing them were inactive.
No activity was demonstrable in 4samples ofurine from post-menopausal women.MAMMOTROPHIC ACTIVITY 245
TABLE I.-Testing Urine Samplesfor Mammotrophic Activity
Club counts + s.e.m
(deaths/10)
A_
Day of Steroids Steroids Steroids
Sample cycle plus urine alone plus prolactin
Normal Young Non-parow Women
RC/I 6 11±4 (1)** 3±1 (1) 36±7 (0) MW/l 20 11±4 (1)**
LF/I 20 5±2 (1) 6±2 (0) 53±13 (0) JF/I 19 14±4 (1)**
MW/2 5 4±2 (4) 5±1 (0) 41±12 (0) JF/2 26 6±2 (0)
EF/I ? 1±1 (3) 8±3 (0) 44±7 (0) AN/I 19 6±6 (5)
JB/I 10 4±3 (3) 8±3 (0) 44±11 (1) JM/l 2 4±3 (6)
KW/I 38 2±1 (0) 5±2 (0) 51±11 (1) AM/1 20 4±2 (3)
MR/I 20 4±1 (4) 11±4 (0) 42±10 (0)
Post-menopausal Hospital Patients
Bri/I 5±2 (4) 5±3 (0) 54±13 (2) Den/l 7±4 (0) Tho/I 2±1 (2) Bed/I 7±2 (1)
Total number of mice 131 79 76
Overall mean 6-0±0- 9 6-4±1- 0 45-3±3- 6
Significantly different (P < 0
-05) from response to steroids alone.
This partial failure to confirm earlier results (Hadfield, 1957) could be attri-
buted to diminished sensitivity of the mice for whereas the club count per mouse
injected with prolactin had been 80-100 previously, it had now fallen to 36-54. Because of this it was decided to see if the responsiveness of the mice could be
improved by modifications of the method of assay.
Simplified testprocedure
The experiments outlined in theAppendix' showed that the mammary response to prolactin was the same as in the original procedure if a smaller total dose of
progest.erone (1 mg.) was given as a single injection of an aqueous suspension on the first day of the test and if a smaller total dose of oestrone (0-1 Itg.) was given twice daily as before but in aqueous solution. The aqueous vehicle greatly eased the dissection of the mammary glands from the pelt. Using this simplified procedure, the dose: response relation for prolactin was almost exactly what it had been using the original procedure (Fig. 1) though the
response to growth hormone was not so satisfactory. Variability of response from
mouse to mouse was still, however, as great as ever.
Tests ofnormalserum
Altogether 13 samples of serum from normal women, 10 of whom were
pregnant, wereinjected in a total dose of I ml. per mouse:in combination with the
simplified steroid dosage. Three of the samples from pregnant women were too
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toxic for any estimate ofmammotrophic activity to be made: they killed all, or
all but one of the m.ice they were injected into. The test mice seem to vary in
their resihence as well as in their mammary responses to serum injections-one
sample (deS) which killed all the mice when first injected killed only one out of
six when the rest ofthesample was tested afortnight later. As therepeat test had
a positive result (Table II), some mammotrophic activity must be retained in
serum during a fortnight ofstorage at 4' C.
TABLE II.-Mammotrophic Activity in Women'8 Serum
Club count ± s.e..
(Number of mice dead in test)
Week of Steroids Steroids + prolactin
Subject pregnancy alone Steroids + serum (I i.u.)
McG 26 11±5 (1/10) 31±14 (5/10) 61±13 (1/10)
Col 31 45±17** (1/6)
mi 38 35±6** (2/10)
deS 19 5±2 (4/10) 21±9* (1/6) 36±7 (3/10)
So 11 14±3** (1/6)
Li 38 31±4* (3/8)
Qu 15 37±13*** (7/10)
Number of mice 15 36 16
Overall mean 9±3 30±4*** 504-8
LF Not 10±4 (0/10) 29+9** (9/13) 43±6 (0/10)
FC pregnant 25±3** (6/12)
ic 32±6*** (2/9)
Number of mice 10 17
Overall mean 10±4 29±3***
Significantly different from response to steroids alone (P < 0-1*, < 0-05**, < 0-01***).
Six of the 7 samples from pregnant women that were tested and all 3 of
the samples from non-pregnant women significantly increased the club count
(Table 11).
DISCUSSION
Mammotrophic activity is used here in a limited and purely empirical sense:
it refers to the capacity to increase the club count in the mammary glands of
hypophysectomized weanling male mice of a particular strain when the mice are
treated with oestrone and progesterone in addition to the material under test.
Our results confirm the earlier evidence (Hadfield, 1957 ; Hadfield andYoung,
1958) that suchactivity is aproperty ofprolactin and ofgrowth hormone and that
it is present in the urine and serum from normal women. Not unexpectedly, we
find it is also present in the serum from pregnant women.
The activity found in normal serum would represent about 0-5-1 i.u. of pro-
lactin or 0-05-0-1 mg. ofgrowth hormone per ml. Current estimates suggest that
normal blood contains 0-002-0-2 i.u. ofprolactin (Simkin and Goodart, 1960) and
0-2 pg. ofgrowth hormone (Read andBryan, 1960) per ml. Thus it isunlikely that
either hormone is alone responsible for the mammotrophic activity in serum. It
is much more probable that the activity represents the resultant effect of bothMAMMOTROPHIC ACTIVITY 247
hormones and possibly of those other hormones that are concerned in mammary
development in rats and mice (Lyons, 1958 ; Nandi, 1959).
The results in Table II show that the method we have used is adequate for
demonstrating the presence of mammotrophic activity in serum. It is not so
satisfactory when applied to neat urine though when the reduced sensitivity of
the mice is taken into consideration weregard the three positive results in Table 1
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FIG. I.-Dose: response lines for prolactin (0-9) and growth hormone (0-0) in 1959 and 1960.
as sufficient confirmation of the more convl'ncing evidence previously obtained
(Hadfield, 1957 ; Hadfield and Young, 1958). It seems that the activity in urine
must be concentrated ifit is to be demonstrated with any regularity. The dose:
response relations for prolactin were very similar to those obtained in a previous
study (Young and Fraser, 1960) using the original steroid dosage but the two sets
of results with growth hormone did not agree so well (Fig. 1). It may be noticed
that both 1959 graphs flatten off at a count of about 50-70 clubs per mouse and
there has been much evidence of a similarplateau in the present experiments with248 FRASER, SPICER, WILLIAMS AND STRETTON YO-UNG
prolactin (see Appendix). This may indicate that the mammary response is
biphasic.
Despite simplification of the injection procedure, the modified club-count
assay described in the Appendix is laborious and the variability of the mammary
response from mouse to mouse severely limits the accuracy with which mam-
motrophic activity can be measured. Taken over several experiments the mean
square error of the mammary response is about 1200, and the slope of the dose :
response curve 20. If the strength of the test preparation is the same as the
standard, the error ofthelog potency ratio (M), which is equivalent to the percent-
age error of the actual potency ratio, is roughly
8 2 S.E. (M) b N
-%vhere 82 iS the niean square error of the response, b the slope ai-id N is the number
of animals. Inserting the above values for .8 and b and correcting to natural logs
it is found that about 120 mice are needed to give 25 per cent accuracy in the
potency ratio. On the whole this is an optimistic estimate, and if the unknown
preparation differed considerably from the standard, the accuracy would be much
lower. On the other hand, the mean square error in some cases may be as low as
600. However there is little doubt that consistently reliable results could only be
obtained by using much larger numbers of animals than is feasible in practice.
It may be that treatment with other hormones concerned in mammarvdevelop-
ment in addition to oestrone and progesterone would increase the sensitivity of
the hvpophysectomized mice or reduce the variability of the response. On the
other'.and, such a procedure might offset one of the advantages of the biological
method in studies of mammary cancer; its measurement of an eff-ective activity
that mav be the resultant of the action of several hormones. Only further studies
can decide this question or whether an alternative and more practicable method of
assay can be devised.
SUMMARY
Ilammotrophic activity was assessed by injecting material to be tested into
hypophysectomizedweanling male mice ofthe A2G strain thatwere beinginjected
at the same time with oestrone and progesterone and counting the increase in the
number of swollen end-buds (clubs) of the mammary ducts.
Omitting samples that killed all, or all but one, of the test animals. activity
was demonstrated in 3 out of I I samples ofurine, and in all of 3 samples of serum,
from normal young women. Six out of 7 samples of serum from pregnant
women were also active. No activity was demonstrable in 4 samples of urine
from women past the menopause.
Some simplification ofthe method oftesting was effected without reducing the
variability of the response. This variability renders the method unsuitable for
quantitative assays at present.
We are verygrateful to the EndocrineStudySection, U.S.A. National Institutes
of Health for generous gifts of prolactin and growth hormone, to Professor N. F.
Morris, Charing Cross Hospital Medical School, for supplying the sera from preg-
nant women, and to Mr. John Gilbert and Mr. Michael Hart for much painstaking
and assiduous technical assistance.MAMMOTROPHIC ACTIVITY 249
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APPENDIX
Attempted Improvement ofthe A88ay
Steroid dO8age
The doses ofoestrone andprogesterone (I /tg. and 5mg.) usedroutinely seemed
unnecessarily large. Reduction of the total doses to 0-1 pg. of oestrone and I mg. ofprogesterone did not influence the club count produced in response to 5 i.u. of
prolactin. The same club count was also induced by I i.u. ofprolactin suggesting that a plateau had been attained in the dose: response curve (Table 111, Experi-
ment A).
Steroid801vents
If lower doses ofthe two steroids were to be used then it should be possible to
substitute a more convenient solvent than arachis oil, which is inconvenient to
handle, persists at the injection site, and often interferes with the clean dissection
of the mammary glands from the pelt.
Fifty per cent aqueous propylene glycol proved an unsatisfactory solvent.
Responses wereusuallyreduced incomparison with testsusing arachis-oil solutions
and the dosegiven (0-I ml. twicedaily) was on the borderline oftoxicity forlarger
TABLE III.-Modification ofA88ay ProcMure
Progesterone
Number Oestrone Prolactin Number
Experi- Steroid Dose of (total dose (total dose of Club
ment solvent (mg.) injections pg.) i.u.) mice count ± s.e.m
A Arachis 5.0 10 1-0 5.0 30 644-6
oil 1-0 10 0.1 5.0 30 72+6
1.0 10 0.1 1.0 27 684-5
B Water i-O I 0.1 5-0 10 78±10
1.0 10 0.1 5-0 8 71±8
2-0 1 0-i 5-0 10 80± 10
2-0 10 0.1 5.0 10 71±2
c Water i-O 10 0-it 5-0 13 61±9
i-O 10 0-1* 5-0 18 57±6
2-0 10 0-it 5.0 8 66±9
2-0 10 0-1* 5.0 10 71±2
t Oestrone and progesterone given together as mixed solution.
* Oestrone and prolactin given together as mixed solution.250 FRASER, SPICER, WILLIAMS ANJ) STRETTON YOUNG
volumes or increased concentration of the solution killed some, or all, of the mice
injected.
The use of aqueous solutions or suspensions, however, had several advantages.
An aqueous suspension of progesterone given as a single subcutaneous injection,
was as effective as the same dose given in 10 injections (Table 111, Experiments
A and B) and aqueous solutions of oestrone could be mixed with the prolactin
solution and injected in combination without affecting the response (Table 111,
Experiment C). This procedure not only reduced the labour ofmultiple injections
but also eased the dissection of the pelts and was therefore adopted in all subse-
quent tests. With this simpler procedure it was possible to undertake a factorial
experiment examining the change in response with variations in dosage of all three
hormones.
Factorial experiment on hormone dosage
A 3 x 3 x 4 factorial experiment was set up with 3 doses of oestrone (0-05,
0
-I and 0
-2/tg.), 3 doses ofprogesterone (O
-5, 1 and 2 mg.) and 4 doses ofprolactin
(0, 0-5, 1 and 2i.u.). There wereoriginally 4 mice in each ofthe 27 groupsreceiving
prolactin and 2 mice in each of the 9 groups receiving no prolactin. Since the
different steroid doses had little, if any, effect on the response to prolactin, no
elaborate statistical formulation need be given. In Table IV the full data are
arranged with reference to prolactin dosage, first without regard to steroid dosage
and then with regard to oestrone dosage and progesterone dosage separately.
Clearly prolactin dosage within the range 0-5-2-0 i.u. had little if any eff-ect on
response and this is true whatever thesteroiddosagewithin therange of0-05-0-2 Itg.
of oestrone and 0-5-2 mg. ofprogesterone.
TABLE IV.-Club Counts s.e.m in Factorial Experiment on Steroid Dosage
Dose ofprolactin in i.u.
(total number of mice)
r
Analysis 0- 0 (16) 0- 5 (34) 1- 0 (33) 2 0 (32)
All iiiice 10+2 46+ 4 51±6 56± 5
Oesti-one
0 05 jig. 12+ 6 504- 8 42± 7 61±9
0- 10 jig. 8±4 47±6 61±11 51+ 10
0- 20 lig. 10+ 2 42±8 50±1) 54 -.- 9
Progesterone
0-5 mg. 13 5 42 -+ 8 36+ 4 51±9
I
- 0 mg. 10±5 46± 6 64±16 60±9
2-0 mg. 8±5 52 -.-- 8 55± IO 56 -4- f
Dose response relationfor prolactin and growth hormone
Since the variation in steroid dosages used in the previous experiment had iio
significant effect on the results, the median doses (I ing. ofprogesterone suspension
and 10 x 0-01 #g. of oestrone in aqueous solution) were used in assays of the
mammotrophic activity of prolactin and growth hormone. The results (Table V)
show clearly how individual variation in response could vitiate conclusions based
on small groups of animals or small differences in dose. With 10 mice per group,MAMMOTROPHIC ACTIVITY 251
TABLIF, V.-Re8pOnM8 to Prolactin or Growth Hormone given with
I mg. Proge8terone and 0-1 Itg. Oe8trone
Prolactin Growth hormone
Dose Club Dose Olub
(i.u.) count + s.e.m (mg.) count ± s.e.m
0 18±4 0 7±4
0-12 45±5 0-03 32±10
0-25 36±9 0-06 24±10
0-50 40±10 0-12 46±15
1.00 72±10 0-25 53±12
2-00 60±8 0.50 25±4
a lower average response can be elicitedby a 4-fold increase in the dose ofprolactin
(compare the responses to 0-12 i.u. and 0-50 i.u.) and a reduction in response on
doubling the dose is common (cf. 0-12-0-25i.u., 1-0-2-0i.u.). Despite this variation
asignificantregression line is achieved (b 22 ± 8-8, t 21-5, 12 D.F., P < 0-05).
With growth hormone, however, a very low average response to the highest dose
made the regression line insignificantly different from horizontal (b 9-5 ± 14-7,
t 0-65. 29 D.R. P < 0-05).